recombinant protein a

Recombinant Proteinase K为一种serine protease，专门裂解脂肪族及芳香族氨基酸的羧基端肽键，适用于蛋白质消化与清除核酸制剂中的污染。

CCT367766 是一种强效的、基于 PROTAC 的第三代异多功能 pirin 靶向蛋白降解探针（PDP），能在低浓度下消耗 pirin 蛋白的表达。CCT367766 对 CRBN-DDB1 复合物的IC50 值为 490 nM。CCT367766 与重组 pirin 和 CRBN 具有良好的亲和力，Kd 值分别为 55 nM 和 120 nM。CCT367766 是一种有效的口服活性蛋白，在低浓度时就可以减少 pirin 蛋白的表达。

NCGC00135472 (DRV1 (GPR32) agonist C2A)是具有促分解功能的人Resolvin D1受体激动剂,可在β阻滞素和 cAMP 测定中激活人溶解蛋白 D1 受体 DRV1 GPR32 受体，EC50 分别为 0.37 uM 和 0.05 uM。NCGC00135472在过表达重组DRV1的细胞中引起快速阻抗变化，刺激血清处理的酶聚糖的吞噬作用。

4-Phenylimidazole（4-Phl）用于研究细胞色素P450与蛋白质-配体相互作用，作为血红素配体在重组人色氨酸2,3-双加氧酶结晶过程中使用。

L-Norvaline 是一种精氨酸酶抑制剂，也是一种非蛋白支链氨基酸。 L-Norvaline 先前已被报道为枯草芽孢杆菌抗真菌肽的天然成分。 L-Norvaline 和其他修饰的支链氨基酸在最近的研究中受到了关注，因为它们似乎被掺入到大肠杆菌中发现的一些重组蛋白中。

β-Glycerophosphate disodium salt hydrate 是一种磷酸酶抑制剂，是内源性代谢产物的一种。

KH7 是腺苷酸环化酶 (sAC) 特异性的可溶性抑制剂，也是一种 cAMP 抑制剂。它对重组纯化的人类 sACt 蛋白和细胞试验中异源表达的 sACt 的 IC50 为 3 到 10 μM 之间。

STO-609 是一种特异性和细胞渗透性的 Ca2+ 钙调蛋白依赖性蛋白激酶激酶抑制剂，用于重组 CaM-KKα 和 CaM-KKβ，Ki 值分别为 80 和 15 ng mL。它抑制 Hela 细胞溶解物中的 AMP 活化蛋白激酶激酶活性，IC50值约为 0.02 g ml。

Beclabuvir (BMS-791325) 是一种高效的 NS5A 复制复合物抑制剂，抑制 HCV 基因型 1，2，4，5 表达的 NS5B 蛋白活性，可用于研究 HCV 感染。

TG-100435是一种新型的多靶点口服蛋白酪氨酸激酶抑制剂。TG100435的代谢通量会被甲巯咪唑和酮康唑完全抑制。在人类肝微粒体或重组P450中，TG100435的形成随细胞色素P450还原酶活性的增加而增加，暗示着细胞色素P450还原酶可能参与其中。

HBX28258 is a recombinant human USP7 protein inhibitor. In human colon cancer and embryonic kidney cell, it acts by binding the active site through a covalent mechanism and selectively inactivating USP7 protein.

CP-609754 是高效的、可逆的法尼基转移酶抑制剂，对重组人 H-Ras 和重组 K-Ras 法尼基化的 IC50分别为 0.57 ng mL 和 46 ng mL。CP-609754有潜在的抗癌作用。

CRA-2059 hydrochloride is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 hydrochloride has the potential for inflammatory bowel disease research[1]. [1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.

CRA-2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase-β (rHTβ)[1][2]. Tryptase is a trypsin-like serine protease found as a major protein component in human mast cell secretory granules. CRA-2059 has the potential for inflammatory bowel disease research[1]. [1]. Tremaine WJ, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407-413.[2]. Selwood T, et al. Potent bivalent inhibition of human tryptase-beta by a synthetic inhibitor. Biol Chem. 2003;384(12):1605-1611.

Defensin HNP-3 is a peptide secreted by human polymorphonuclear leukocytes (PMNs) that has antimicrobial properties. It induces lysis of mammalian cells when used at a concentration of 25 μg mL. It also inhibits growth of E. faecalis (ED50 = 100 nM) and clinical isolates of P. aeruginosa (MIC90 = 4 μM). HNP-3 binds to recombinant HIV-1 envelope glycoprotein (gp120) and human CD4 (Kds = 52.8 and 34.9 nM, respectively). It also binds to recombinant, immobilized human surfactant protein D (SP-D; Kd = 55.7 nM) and inhibits focus formation in Madin-Darby canine kidney (MDCK) cells infected with influenza A virus (IAV).

FATP1-IN-1 是一种强效的脂肪酸转运蛋白1（FATP1）抑制剂。它能有效抑制对FATP1功能至关重要的重组人类或小鼠的酰辅酶A合成酶活性。其抑制特征通过IC50值体现，分别为人类FATP1的0.046 μM 和小鼠FATP1的0.60 μM。

MD2-IN-1 是骨髓分化蛋白 2 (MD2) 的抑制剂，对重组人 MD2 (rhMD2) 的 KD 为 189  μM。

CHD1Li 6.11 是一种致癌 CHD1L 的有效抑制剂，能够作用于 cat-CHD1L 重组蛋白 (IC50: 3.3 μM)。CHD1Li 6.11 是一种口服具有活力的抗肿瘤剂，明显减少由分离的准间充质细胞 (M 表型) 产生的 CRC 异种移植物的肿瘤体积，这些细胞具有增强的致瘤特性。

AS1940477 is p38 MAPK inhibitor. AS1940477 inhibited the enzymatic activity of recombinant p38α and β isoforms but showed no effect against other 100 protein kinases including p38γ and δ isoforms. In human peripheral blood mononuclear cells, AS1940477 inhibited lipopolysaccharide (LPS)- or phytohemagglutinin A (PHA)-induced production of proinflammatory cytokines, including TNFα, IL-1β, and IL-6 at low concentrations (LPS TNFα, IC(50)=0.45n M; PHA TNFα, IC(50)=0.40 nM). In addition, equivalent concentrations of AS1940477 that inhibited cytokine production also inhibited TNFα- and IL-1 β-induced production of IL-6, PGE(2), and MMP-3 in human synovial stromal cells. AS1940477 was also found to potently inhibit TNF production in whole blood (IC(50)=12 nM) and effectively inhibited TNFα production induced by systemically administered LPS in rats at less than 0.1mg kg (ED(50)=0.053 mg kg) with an anti-inflammatory effect lasting for 20h after oral administration. Overall, this stu......

Sekikaic acid is a phenolic lichen metabolite that has been found in H. obscurata and has diverse biological activities. It scavenges superoxide and DPPH radicals in cell-free assays when used at a concentration of 0.5 µM. Sekikaic acid is active against the rg recombinant strain of respiratory syncytial virus (RSV; IC50 = 5.69 µg ml). It inhibits the protein-protein interaction between mixed lineage leukemia 1 (MLL1) and the GACKIX domain of CREB-binding protein (CBP; IC50 = 34 µM).

Lobaric acid is a depsidone metabolite that has been isolated from Stereocaulon lichen species with antioxidant, antiproliferative, antiviral, and enzyme inhibitory activites. It scavenges superoxide radicals in a cell-free assay (IC50 = 97.9 μmol) and inhibits proliferation in a panel of leukemia, colorectal, gastric, breast, ovarian, prostate, pancreatic, and lung cancer cell lines (EC50s = 15.2-63.9 μg ml). Lobaric acid inhibits protein tyrosine phosphatase 1B (PTP1B; IC50 = 0.87 μM for the human recombinant enzyme) and production of 12(S)-HETE (Item No. 34570) by 12(S)-lipoxygenase (IC50 = 28.5 μM). In vivo, lobaric acid (250 μM) decreases lesion number, but not lesion diameter, in tobacco leaves infected with tobacco mosaic virus (TMV).

ALN29882 is a glycerolipid, that is located at the plasma membrane. It is made up of two fatty acid chains that are covalently attached to a single glycerol molecule with the help of an ester linkage. 18:1 DG has been used as a diacyl-glycerol source in diacylglycerol O-acyltransferase 1 (DGAT1) assay. It has also been used as substrate to assess compounds as potential inhibitors of DGAT-1 in DGAT-1 enzyme assay. It is suitable to use in lipid-protein overlay screen assay with the recombinant protein His-AtROP6.

Anpocogin 是 Ancyclostoma canium 线虫的抗凝蛋白 c2 变体（添加了 C 末端 P85）。Anpocogin 在Pichia pastoris 中产生，用作抗凝剂。重组线虫抗凝蛋白c2 （rNAPc2）是丝氨酸蛋白酶因子VIIa及其细胞相关辅因子组织因子FVIIa TF的有效抑制剂， FVIIa TF是血液凝固的关键生理启动剂，在治疗弥散性血管内凝血病和静脉和动脉血栓方面具有潜在的疗效。

Tucotuzumab (Anti-EPCAM Recombinant Antibody) 一种由人上皮细胞粘附分子 (EpCAM) 抗原特异性 IgG1 单克隆抗体组成的蛋白质，与两个 IL-2分子相连。Tucotuzumab 是一种免疫抑制剂和抗肿瘤活性分子。